These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

253 related items for PubMed ID: 29984653

  • 1. Amyloid and Tau Positron Emission Tomography in Suggested Diabetesrelated Dementia.
    Takenoshita N, Fukasawa R, Ogawa Y, Shimizu S, Umahara T, Ishii K, Shimada H, Higuchi M, Suhara T, Hanyu H.
    Curr Alzheimer Res; 2018; 15(11):1062-1069. PubMed ID: 29984653
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Concordance between cerebrospinal fluid biomarkers and [11C]PIB PET in a memory clinic cohort.
    Zwan M, van Harten A, Ossenkoppele R, Bouwman F, Teunissen C, Adriaanse S, Lammertsma A, Scheltens P, van Berckel B, van der Flier W.
    J Alzheimers Dis; 2014; 41(3):801-7. PubMed ID: 24705549
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Quantitative analysis of regional distribution of tau pathology with 11C-PBB3-PET in a clinical setting.
    Yousefzadeh-Nowshahr E, Winter G, Bohn P, Kneer K, von Arnim CAF, Otto M, Solbach C, Anderl-Straub S, Polivka D, Fissler P, Strobel J, Kletting P, Riepe MW, Higuchi M, Glatting G, Ludolph A, Beer AJ, Alzheimer’s Disease Neuroimaging Initiative.
    PLoS One; 2022; 17(4):e0266906. PubMed ID: 35404966
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Pittsburgh Compound B and AV-1451 positron emission tomography assessment of molecular pathologies of Alzheimer's disease in progressive supranuclear palsy.
    Whitwell JL, Ahlskog JE, Tosakulwong N, Senjem ML, Spychalla AJ, Petersen RC, Jack CR, Lowe VJ, Josephs KA.
    Parkinsonism Relat Disord; 2018 Mar; 48():3-9. PubMed ID: 29254665
    [Abstract] [Full Text] [Related]

  • 11. Identification of diabetes-related dementia: Longitudinal perfusion SPECT and amyloid PET studies.
    Fukasawa R, Hanyu H, Shimizu S, Kanetaka H, Sakurai H, Ishii K.
    J Neurol Sci; 2015 Feb 15; 349(1-2):45-51. PubMed ID: 25573776
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. In vivo direct relation of tau pathology with neuroinflammation in early Alzheimer's disease.
    Terada T, Yokokura M, Obi T, Bunai T, Yoshikawa E, Ando I, Shimada H, Suhara T, Higuchi M, Ouchi Y.
    J Neurol; 2019 Sep 15; 266(9):2186-2196. PubMed ID: 31139959
    [Abstract] [Full Text] [Related]

  • 15. Amyloid deposition and CBF patterns predict conversion of mild cognitive impairment to dementia.
    Kikukawa T, Abe T, Ataka S, Saito H, Hasegawa I, Mino T, Takeuchi J, Kawabe J, Wada Y, Watanabe Y, Itoh Y.
    Neurol Sci; 2018 Sep 15; 39(9):1597-1602. PubMed ID: 29936556
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. A Cross-Validation of FDG- and Amyloid-PET Biomarkers in Mild Cognitive Impairment for the Risk Prediction to Dementia due to Alzheimer's Disease in a Clinical Setting.
    Iaccarino L, Chiotis K, Alongi P, Almkvist O, Wall A, Cerami C, Bettinardi V, Gianolli L, Nordberg A, Perani D.
    J Alzheimers Dis; 2017 Sep 15; 59(2):603-614. PubMed ID: 28671117
    [Abstract] [Full Text] [Related]

  • 18. AV-1451 tau and β-amyloid positron emission tomography imaging in dementia with Lewy bodies.
    Kantarci K, Lowe VJ, Boeve BF, Senjem ML, Tosakulwong N, Lesnick TG, Spychalla AJ, Gunter JL, Fields JA, Graff-Radford J, Ferman TJ, Jones DT, Murray ME, Knopman DS, Jack CR, Petersen RC.
    Ann Neurol; 2017 Jan 15; 81(1):58-67. PubMed ID: 27863444
    [Abstract] [Full Text] [Related]

  • 19. Amyloid, hypometabolism, and cognition in Alzheimer disease: an [11C]PIB and [18F]FDG PET study.
    Edison P, Archer HA, Hinz R, Hammers A, Pavese N, Tai YF, Hotton G, Cutler D, Fox N, Kennedy A, Rossor M, Brooks DJ.
    Neurology; 2007 Feb 13; 68(7):501-8. PubMed ID: 17065593
    [Abstract] [Full Text] [Related]

  • 20. Circadian Rest-Activity Pattern Changes in Aging and Preclinical Alzheimer Disease.
    Musiek ES, Bhimasani M, Zangrilli MA, Morris JC, Holtzman DM, Ju YS.
    JAMA Neurol; 2018 May 01; 75(5):582-590. PubMed ID: 29379963
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.